https://allsci.com/news/first-in-human-trials/oral-insulin-nanoparticles-endo-axiom-doses-first/ AllScien 2026-09-11T17:29:22.213189Z Endo Axiom takes oral nanoparticle insulin into first-in-human trial https://allsci.com/news/debt-financing/teva-debt-refinancing-refinances-usd-49b-pile-at/ AllScien 2026-09-11T17:17:58.793367Z Teva raises USD 4.9bn to refinance higher-coupon debt https://allsci.com/news/licensing-and-partnerships/imunon-nci-partnership-cancer-with-national/ AllScien 2026-09-11T15:59:10.272768Z IMUNON partners with National Cancer Institute to expand IL-12 DNA plasmid beyond ovarian cancer https://allsci.com/news/licensing-and-partnerships/dmd-gene-therapy-collaboration-exegenesis-and/ AllScien 2026-09-11T15:36:46.345928Z Exegenesis and Modalis combine muscle-targeting AAV with epigenome editing for preclinical DMD candidate https://allsci.com/news/funding/yarrow-bioscience-funding-graves-disease/ AllScien 2026-09-11T15:31:28.875108Z Yarrow raises USD 150m to advance first-in-class Graves' disease antibody into Phase II https://allsci.com/news/clinical-trials/deep-brain-ultrasound-essential-tremor/ AllScien 2026-09-11T15:23:07.182481Z NeuroHarmonics launches first patient trial of non-invasive deep-brain ultrasound for essential tremor https://allsci.com/news/first-in-human-trials/oral-glp-1-peptide-gan-lee-advances-once-weekly/ AllScien 2026-09-11T14:58:08.989378Z Gan & Lee advances once-weekly oral GLP-1 peptide into Phase I https://allsci.com/news/grants/necrotizing-enterocolitis-research-johns-hopkins/ AllScien 2026-09-11T13:56:37.983291Z Johns Hopkins tests pancreatic TLR4–hyperglycemia axis as driver of necrotizing enterocolitis https://allsci.com/news/regulatory/zanzalintinib-fda-approval-extends-exelixis/ AllScien 2026-09-11T13:45:04.918848Z FDA extends Exelixis' zanzalintinib review by three months, pushing decision to March 2027